Legacy R&D systems fragment data, limiting integration, collaboration and AI readiness across product development workflows.

Job Description We are seeking a passionate and innovative Genomic Data Scientist to join our Bioinformatics Research ...

A recent preprint claims that we may someday be able to create gravitational waves in a lab. Through the use of “twisted” light, we could create powerful, high-frequency waves in a controlled setting.

AST SpaceMobile aims to eliminate dead zones by building a satellite constellation that connects directly to the billions of mobile phones already in use. The company works with mobile network ...

Roku TV vs Fire Stick Galaxy Buds 3 Pro vs Apple AirPods Pro 3 M5 MacBook Pro vs M4 MacBook Air Linux Mint vs Zorin OS 4 quick steps to make your Android phone run like new again How much RAM does ...

You can now ask the Gemini app to directly generate “downloadable and ready-to-share files.” Google wants you to “quickly move from a brainstorm to a complete ...

If Python developers have one consistent gripe about their beloved language, it tends to be this: Why is it so hard to take a Python program and deploy it as a standalone artifact, the way C, C++, ...

Google has updated Gemini to generate and package downloadable files like PDFs, Word, and Excel directly in the chat. This new feature, available globally, aims to eliminate the need for manual ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. In ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...